| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in YDES over the last quarter tilts toward buying: insiders added a net 34,178 shares worth roughly $129K.
Classified under Biotechnology (Healthcare sector), YDES's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 11.26M | $43.34M | - | |
| Dir | 3.1K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Shen Ethan Phd | CEO | Buy | 12,700 | $3.85 | $48,895.00 | +0.1% | |
| Sep 9, 2026 | Shen Ethan Phd | CEO | Buy | 3,100 | $3.93 | $12,183.00 | - | |
| Sep 4, 2026 | Shen Ethan Phd | CEO | Buy | 18,378 | $3.67 | $67,447.26 | +0.2% |